Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

$40.46
-0.29 (-0.71%)
NYSE
USD, US
Drug Manufacturers - General

52 Week Range

39.35-65.38

Beta

0.44

Market Cap

$82.02B

Last Dividend

2.4

PE (TTM)

-13.31

Dividend Yield (TTM)

0.06

Price Chart

Industry

Drug Manufacturers - General

Sector

Healthcare

CEO

Dr. Christopher S. Boerner Ph.D.

Full-Time Employees

34,100

IPO Date

1972-06-01

Description

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a protein-bound chemotherapy product; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; and Empliciti for the treatment of multiple myeloma. In addition, the company offers Zeposia to treat relapsing forms of multiple sclerosis; Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Inrebic, an oral kinase inhibitor indicated for the treatment of adult patients with myelofibrosis; and Onureg for the treatment of adult patients with AML. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.

Phone

212 546 4000

Address

430 East 29th Street, New York, NY, 10016, US

CIK

0000014272